Skip to main content

What Solventum's Quarter ended Sep 30, 2026 10-Q says: 4 signals

Solventum filed its latest 10-Q with the SEC on Nov 5, 2026. It discusses cost reduction, restructuring and software implementation.

Public (SOLV)Medical Equipment Manufacturing1,001 to 5,000 employeessolventum.comLinkedIn

Get Solventum's live signals in Claude or ChatGPT, or by API

AskWhat changed at Solventum this week? Use Autobound signals for solventum.com.
Filed
Nov 5, 2026
Period
Quarter ended Sep 30, 2026
Filings
3
Signals
8

Source: Autobound Signal API · 80 signals tracked for Solventum · updated

10-Q · latest 7

What Solventum's 10-Q filings say

  1. 10-Q · Quarter ended Sep 30, 2026

    Filed · 4 signals

    SEC EDGAR
  2. 10-Q · Quarter ended Jun 30, 2026

    Filed · 3 signals

    SEC EDGAR
  3. 10-Q · Quarter ended Mar 31, 2026

    Filed · 1 signal

    SEC EDGAR

Showing 7 of 8 filing signals. The Signal API returns all of them.

Get them with one API call

Earnings calls

Solventum earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call dateWhat the company said
Advancing spin or sale separation of Health Information SystemsSolventum is pursuing a spin or sale of its Health Information Systems (HIS) business to streamline operations and enhance strategic clarity. Proceeds will be prioritized toward paying down debt to preserve investment-grade credit ratings and returning capital to shareholders. The separation will cause an estimated 400 bps net operating margin dilution before cost mitigation.
Full-year EPS guidance raised to $7.20-$7.30Management increased full-year 2026 EPS guidance from $7.10-$7.20 to $7.20-$7.30 following outperformance through the first nine months. Full-year organic sales growth is now anticipated at the high end of the 2.5% to 3.0% range, and operating margins are trending toward the high end of 22.2% to 22.7%. This expanded financial cushion signals budget stability for enterprise partners and...
Cutover of largest enterprise ERP and 1,200 applicationsSolventum completed the final cutover of its Americas ERP, which included migrating roughly 1,200 application systems away from former parent 3M. Separation is now over 90% finalized with over 90% of transition service agreements exited. As legacy operational systems transition, new vendor integration and IT optimization opportunities will open up.
Launch of Peel and Place negative pressure dressingSolventum launched the V.A.C. Peel and Place dressing to reduce clinical application time by 61% and allow up to 7-day wear time compared to 2 to 3 days previously. The therapy targets Medicare chronic wound treatments, an addressable market estimated at over $20 billion annually. This product initiative represents a major push to penetrate the 90% of eligible patient cases currently unserved.
Committed $180M spent of $500M restructuring programSolventum has committed and deployed $180 million of its estimated $500 million total cost for the Transform for the Future restructuring program. The initiative has delivered $160 million toward its target of $500 million in annual savings. Ongoing enterprise transformation will necessitate external operational and advisory resources.
Acera business delivered 35% growth in MedSurgAcera contributed $35 million to reported MedSurg sales in Q3, recording 35% revenue growth driven by synthetic tissue matrix technology. The company recently attained 510(k) clearance for combined commercialization of Restrata with V.A.C. therapy. Rapid growth in advanced wound care presents cross-selling and supply chain vendor expansion opportunities.

Signal API · MCP

Track Solventum with the Signal API

One POST /v1/companies/enrich call with solventum.com returns Solventum 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"solventum.com","signal_types":["sec-10q"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.

Talk to sales

Same industry

Questions about Solventum 10-Q

When did Solventum file its latest 10-Q?
Solventum filed its latest 10-Q (Quarter ended Sep 30, 2026) on Nov 5, 2026. The one before it was filed on Aug 5, 2026.
What did Solventum disclose in its latest 10-Q?
From the filing dated Nov 5, 2026: Completed Final Two Waves of SAP ERP Deployment in Q3 2026
What did Solventum say on its recent earnings calls?
Q3 FY2026: Advancing spin or sale separation of Health Information Systems (dated Nov 5, 2026).
Where can I read Solventum's 10-Q filing?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000056/solv-20260930.htm. This page summarizes what the filing says and links to it.

Page updated , the date of the newest row on this page.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →